Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

FDA Rejects Lindane Petition

by Britt E. Erickson
December 10, 2012 | A version of this story appeared in Volume 90, Issue 50

[+]Enlarge
Credit: iStock
Head lice
Head lice
Credit: iStock
Head lice

FDA has denied a petition to immediately ban lindane, the active ingredient in some shampoos and lotions used to treat head lice and scabies. The petition, filed in 2010 by the Natural Resources Defense Council and other environmental groups, argues that lindane has been associated with numerous adverse health effects and is no longer effective because pests have developed resistance to it. EPA banned the use of lindane, an organochlorine pesticide, in agriculture in 2006 because of toxicity concerns. FDA rejected NRDC’s petition, saying, “If lindane were to be removed from the market, patients would have very limited options for treatment of scabies, especially given the failure rate of the other FDA-approved therapies.”

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.